The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

• Cui Chen ,

  Contributed equally to this work with: Cui Chen, Peng Sun, Qiang-sheng Dai

  Affiliation Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

  ⨯
• Peng Sun ,

  Contributed equally to this work with: Cui Chen, Peng Sun, Qiang-sheng Dai

  Affiliations Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China

  ⨯
• Qiang-sheng Dai ,

  Contributed equally to this work with: Cui Chen, Peng Sun, Qiang-sheng Dai

  Affiliation Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

  ⨯
• Hui-wen Weng,

  Affiliation Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

  ⨯
• He-ping Li,

  Affiliation Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

  ⨯
• Sheng Ye

  * E-mail: yes20111212@163.com

  Affiliation Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

  ⨯